Bio Green Med Solution, Inc. (NASDAQ: BGMSP) Stock Competitors & Peer Comparison
See BGMSP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BGMSP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BGMSP | $1.10 | +0.00% | 2.4M | -0.84 | -$1.31 | N/A |
| RPRX | $66.52 | -0.98% | 29.6B | 12.67 | $5.25 | +1.38% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| CORT | $80.46 | -0.81% | 8.7B | 229.89 | $0.35 | N/A |
| KNSA | $90.80 | -1.56% | 7.1B | 69.77 | $1.30 | N/A |
| LQDA | $41.85 | -7.12% | 3.7B | 30.55 | $1.37 | N/A |
| PBH | $49.73 | +1.37% | 2.4B | 11.26 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $13.51 | -3.15% | 811.5M | -5.35 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
BGMSP vs RPRX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, RPRX has a market cap of 29.6B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while RPRX trades at $66.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas RPRX's P/E ratio is 12.67. In terms of profitability, BGMSP's ROE is -0.32%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, BGMSP is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check RPRX's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
BGMSP vs WBA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas WBA's P/E ratio is -1.64. In terms of profitability, BGMSP's ROE is -0.32%, compared to WBA's ROE of -0.57%. Regarding short-term risk, BGMSP is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check WBA's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
BGMSP vs CORT Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, CORT has a market cap of 8.7B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while CORT trades at $80.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas CORT's P/E ratio is 229.89. In terms of profitability, BGMSP's ROE is -0.32%, compared to CORT's ROE of +0.08%. Regarding short-term risk, BGMSP is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check CORT's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
BGMSP vs KNSA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, KNSA has a market cap of 7.1B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while KNSA trades at $90.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas KNSA's P/E ratio is 69.77. In terms of profitability, BGMSP's ROE is -0.32%, compared to KNSA's ROE of +0.17%. Regarding short-term risk, BGMSP is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
BGMSP vs LQDA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, LQDA has a market cap of 3.7B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while LQDA trades at $41.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas LQDA's P/E ratio is 30.55. In terms of profitability, BGMSP's ROE is -0.32%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, BGMSP is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
BGMSP vs PBH Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while PBH trades at $49.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas PBH's P/E ratio is 11.26. In terms of profitability, BGMSP's ROE is -0.32%, compared to PBH's ROE of +0.09%. Regarding short-term risk, BGMSP is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
BGMSP vs HROWL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas HROWL's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, BGMSP is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
BGMSP vs HROWM Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas HROWM's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, BGMSP is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
BGMSP vs LTGO Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, LTGO has a market cap of 811.5M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while LTGO trades at $13.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas LTGO's P/E ratio is -5.35. In terms of profitability, BGMSP's ROE is -0.32%, compared to LTGO's ROE of N/A. Regarding short-term risk, BGMSP is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
BGMSP vs HELP Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, HELP has a market cap of 545.5M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while HELP trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas HELP's P/E ratio is -2.11. In terms of profitability, BGMSP's ROE is -0.32%, compared to HELP's ROE of -0.71%. Regarding short-term risk, BGMSP is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
BGMSP vs SVA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas SVA's P/E ratio is -5.68. In terms of profitability, BGMSP's ROE is -0.32%, compared to SVA's ROE of -0.01%. Regarding short-term risk, BGMSP is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
BGMSP vs CUVL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, CUVL has a market cap of 249.9M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while CUVL trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas CUVL's P/E ratio is 10.68. In terms of profitability, BGMSP's ROE is -0.32%, compared to CUVL's ROE of N/A. Regarding short-term risk, BGMSP is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
BGMSP vs HITI Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, HITI has a market cap of 230.9M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while HITI trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas HITI's P/E ratio is -9.57. In terms of profitability, BGMSP's ROE is -0.32%, compared to HITI's ROE of -0.36%. Regarding short-term risk, BGMSP is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
BGMSP vs CELG-RI Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, CELG-RI has a market cap of 194.1M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while CELG-RI trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, BGMSP is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check CELG-RI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
BGMSP vs ETRA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, ETRA has a market cap of 155.1M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while ETRA trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas ETRA's P/E ratio is -2.76. In terms of profitability, BGMSP's ROE is -0.32%, compared to ETRA's ROE of N/A. Regarding short-term risk, BGMSP is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
BGMSP vs TRXB Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, TRXB has a market cap of 114.4M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while TRXB trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas TRXB's P/E ratio is -5.56. In terms of profitability, BGMSP's ROE is -0.32%, compared to TRXB's ROE of N/A. Regarding short-term risk, BGMSP is less volatile compared to TRXB. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check TRXB's competition here
Atlantic International Corp. (NASDAQ: ATLN)
BGMSP vs ATLN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas ATLN's P/E ratio is -0.68. In terms of profitability, BGMSP's ROE is -0.32%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, BGMSP is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
BGMSP vs CTOR Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, CTOR has a market cap of 55.2M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while CTOR trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas CTOR's P/E ratio is -1.26. In terms of profitability, BGMSP's ROE is -0.32%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, BGMSP is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check CTOR's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
BGMSP vs RTSN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, RTSN has a market cap of 43.6M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while RTSN trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas RTSN's P/E ratio is -4.45. In terms of profitability, BGMSP's ROE is -0.32%, compared to RTSN's ROE of N/A. Regarding short-term risk, BGMSP is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
BGMSP vs RAD Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas RAD's P/E ratio is -0.05. In terms of profitability, BGMSP's ROE is -0.32%, compared to RAD's ROE of +2.76%. Regarding short-term risk, BGMSP is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
BGMSP vs GLTO Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas GLTO's P/E ratio is -1.78. In terms of profitability, BGMSP's ROE is -0.32%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, BGMSP is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check GLTO's competition here
Cosmos Health Inc. (NASDAQ: COSM)
BGMSP vs COSM Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while COSM trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas COSM's P/E ratio is -0.42. In terms of profitability, BGMSP's ROE is -0.32%, compared to COSM's ROE of -1.19%. Regarding short-term risk, BGMSP is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check COSM's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
BGMSP vs NSRX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, NSRX has a market cap of 27.6M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while NSRX trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas NSRX's P/E ratio is -4.44. In terms of profitability, BGMSP's ROE is -0.32%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, BGMSP is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
BGMSP vs SCYX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, SCYX has a market cap of 24M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while SCYX trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas SCYX's P/E ratio is -1.11. In terms of profitability, BGMSP's ROE is -0.32%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, BGMSP is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check SCYX's competition here
Pomdoctor Limited (NASDAQ: POM)
BGMSP vs POM Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, POM has a market cap of 16.4M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while POM trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas POM's P/E ratio is -0.28. In terms of profitability, BGMSP's ROE is -0.32%, compared to POM's ROE of +0.80%. Regarding short-term risk, BGMSP is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check POM's competition here
Biofrontera Inc. (NASDAQ: BFRI)
BGMSP vs BFRI Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while BFRI trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas BFRI's P/E ratio is -1.59. In terms of profitability, BGMSP's ROE is -0.32%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, BGMSP is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
BGMSP vs CNSY Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, CNSY has a market cap of 12.9M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while CNSY trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas CNSY's P/E ratio is -0.41. In terms of profitability, BGMSP's ROE is -0.32%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, BGMSP is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check CNSY's competition here
Azora Therapeutics, Inc. (NASDAQ: AZR)
BGMSP vs AZR Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, AZR has a market cap of 10.4M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while AZR trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas AZR's P/E ratio is -0.24. In terms of profitability, BGMSP's ROE is -0.32%, compared to AZR's ROE of N/A. Regarding short-term risk, BGMSP is less volatile compared to AZR. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check AZR's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
BGMSP vs CJJD Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas CJJD's P/E ratio is -0.46. In terms of profitability, BGMSP's ROE is -0.32%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, BGMSP is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
BGMSP vs SSY Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas SSY's P/E ratio is -2.86. In terms of profitability, BGMSP's ROE is -0.32%, compared to SSY's ROE of -0.09%. Regarding short-term risk, BGMSP is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
BGMSP vs SCNX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while SCNX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas SCNX's P/E ratio is -1.54. In terms of profitability, BGMSP's ROE is -0.32%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, BGMSP is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
BGMSP vs BGMS Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas BGMS's P/E ratio is -0.25. In terms of profitability, BGMSP's ROE is -0.32%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, BGMSP is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check BGMS's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
BGMSP vs MDVL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas MDVL's P/E ratio is -0.05. In terms of profitability, BGMSP's ROE is -0.32%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, BGMSP is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check MDVL's competition here
Eocene Ltd. (NASDAQ: EOCN)
BGMSP vs EOCN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, EOCN has a market cap of 2.8M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while EOCN trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas EOCN's P/E ratio is -0.19. In terms of profitability, BGMSP's ROE is -0.32%, compared to EOCN's ROE of N/A. Regarding short-term risk, BGMSP is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check EOCN's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
BGMSP vs PAVS Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, PAVS has a market cap of 2.7M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while PAVS trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas PAVS's P/E ratio is -0.03. In terms of profitability, BGMSP's ROE is -0.32%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, BGMSP is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
BGMSP vs ATNFW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas ATNFW's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, BGMSP is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check ATNFW's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
BGMSP vs AZNH Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas AZNH's P/E ratio is 38.35. In terms of profitability, BGMSP's ROE is -0.32%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, BGMSP is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check AZNH's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP)
BGMSP vs ASBP Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, ASBP has a market cap of 842.2K. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while ASBP trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas ASBP's P/E ratio is -0.31. In terms of profitability, BGMSP's ROE is -0.32%, compared to ASBP's ROE of +19.93%. Regarding short-term risk, BGMSP is less volatile compared to ASBP. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check ASBP's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
BGMSP vs BFRIW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while BFRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas BFRIW's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, BGMSP is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check BFRIW's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
BGMSP vs LFLYW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, BGMSP's ROE is -0.32%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, BGMSP is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check LFLYW's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBPW)
BGMSP vs ASBPW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while ASBPW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas ASBPW's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, BGMSP is less volatile compared to ASBPW. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check ASBPW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
BGMSP vs PRPH Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, PRPH has a market cap of 91.1K. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas PRPH's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, BGMSP is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check PRPH's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
BGMSP vs OREX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, OREX has a market cap of 0. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas OREX's P/E ratio is -0.14. In terms of profitability, BGMSP's ROE is -0.32%, compared to OREX's ROE of -0.54%. Regarding short-term risk, BGMSP is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check OREX's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
BGMSP vs ESRX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas ESRX's P/E ratio is 10.69. In terms of profitability, BGMSP's ROE is -0.32%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, BGMSP is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check ESRX's competition here
POZEN Inc. (NASDAQ: POZN)
BGMSP vs POZN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, POZN has a market cap of 0. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas POZN's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to POZN's ROE of +0.61%. Regarding short-term risk, BGMSP is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check POZN's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
BGMSP vs IPXL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas IPXL's P/E ratio is -10.11. In terms of profitability, BGMSP's ROE is -0.32%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, BGMSP is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for BGMSP.Check IPXL's competition here
Shire plc (NASDAQ: SHPG)
BGMSP vs SHPG Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas SHPG's P/E ratio is 11.35. In terms of profitability, BGMSP's ROE is -0.32%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, BGMSP is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check SHPG's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
BGMSP vs CPD Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMSP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMSP stands at 2.4M. In comparison, CPD has a market cap of 0. Regarding current trading prices, BGMSP is priced at $1.10 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMSP currently has a P/E ratio of -0.84, whereas CPD's P/E ratio is N/A. In terms of profitability, BGMSP's ROE is -0.32%, compared to CPD's ROE of N/A. Regarding short-term risk, BGMSP is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for BGMSP.Check CPD's competition here